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Background: Homologous recombination is regulated both positively and negatively in eukaryotic cells to suppress
genomic instability.
Results: FBH1 can disrupt RAD51 filaments in vitro and suppresses formation of spontaneous RAD51 foci in mammalian cells.
In cells defective for FBH1, hyper-recombination is observed.
Conclusion: FBH1 is a negative regulator of homologous recombination.
Significance: RAD51 activity must be carefully controlled to preserve genomic integrity.
Efficient repair of DNA double strand breaks and interstrand
cross-links requires the homologous recombination (HR) path-
way, a potentially error-free process that utilizes a homologous
sequence as a repair template. A key player in HR is RAD51, the
eukaryotic ortholog of bacterial RecA protein. RAD51 can
polymerize on DNA to form a nucleoprotein filament that facil-
itates both the search for the homologous DNA sequences and
the subsequent DNA strand invasion required to initiate HR.
Because of its pivotal role in HR, RAD51 is subject to numerous
positive and negative regulatory influences. Using a combina-
tionofmolecular genetic, biochemical, and single-molecule bio-
physical techniques, we provide mechanistic insight into the
mode of action of the FBH1 helicase as a regulator of RAD51-
dependent HR in mammalian cells. We show that FBH1 binds
directly to RAD51 and is able to disrupt RAD51 filaments on
DNA through its ssDNA translocase function. Consistent with
this, a mutantmouse embryonic stem cell line with a deletion in
the FBH1 helicase domain fails to limit RAD51 chromatin asso-
ciation and shows hyper-recombination. Our data are consis-
tent with FBH1 restraining RAD51 DNA binding under unper-
turbed growth conditions to prevent unwanted or unscheduled
DNA recombination.
Homologous recombination (HR)5 is an evolutionarily con-
served pathway for the repair of DNA double strand breaks,
DNA interstrand cross-links, and collapsed replication forks.
DNA repair mediated by HR requires a homologous template,
which in proliferating cells is generally the sister chromatid
generated in S-phase (1). In diploid organisms, HR can also
utilize the homologous chromosome as a template, but this is
disfavored wherever possible because it can lead to loss of
heterozygosity (LOH), a potential driver of tumorigenesis (2).
Indeed, many of the homozygous mutations found in tumor
suppressor genes in neoplastic cells probably arose via LOH
following an initial, monoallelic mutational event. A pivotal
player in HR is the RAD51 protein (RecA in bacteria), a DNA-
dependentATPasethatpolymerizesonssDNAtoformanucleo-
protein filament. This structure is a central intermediate in HR
and is necessary for DNA strand invasion to occur as part of the
search for a homologous DNA sequence (1, 3).
Because of the potential for HR to generate LOH or other
forms of genome rearrangements, it is critical that cells care-
fully regulate the process. Several factors have been identified
that actively assist RAD51 at the DNA strand invasion step of
HR, including BRCA2, RAD54, and the so-called RAD51 para-
logs in eukaryotes (4–6). Similarly, RAD51 is subject to nega-
tive regulation in order to prevent inadvertent or unwantedHR
reactions. One form of regulation is via the disruption of
RAD51 filaments. The best characterized factor to perform this
task is the yeast Srs2 protein, a superfamily 1 DNA helicase
belonging to the highly conserved UvrD family (7). Srs2 utilizes
the energy derived from ATP hydrolysis to translocate on
ssDNA, a process that serves to progressively disrupt the Rad51
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filament (8). Srs2 also binds directly to yeast Rad51. Moreover,
genetic and biochemical evidence in yeast is fully consistent
with Srs2 playing a role in Rad51 filament disruption and in
restraining HR in the cell (9, 10).
In addition to Srs2, there are other UvrD family members
expressed in eukaryotic cells. A recently identified familymem-
ber in human cells is PARI (11). This protein also binds to
RAD51, but it contains amino acid substitutions in critical res-
idues required for ATPase function, and hence PARI is not an
active helicase/translocase. How PARI regulates RAD51 func-
tion at a mechanistic level is not known. Another eukaryotic
UvrD family member is the F-box helicase 1 (FBH1), which is
found in fission yeast and higher eukaryotes but not in budding
yeast (12). FBH1 is a bifunctional protein comprising an N-ter-
minal F-box domain and a centrally located helicase domain.
Previous biochemical studies have indicated that human FBH1
is an activeDNAhelicase/translocase (12). The F-box domain is
involved in the post-translational modification of proteins as
part of the so-called SCF complex (Skp1-Cul1-Fbh1), which
serves as an E3 ubiquitin ligase (13). The targets for the FBH1
F-box in human cells remain to be identified.
Genetic studies in the fission yeast, S. pombe, have provided
strong evidence that Fbh1 regulates Rad51 function in that
organism. Deletion of S. pombe fbh1 leads to mild sensitivity to
certain DNA-damaging agents as well as to the formation of
spontaneous foci containing Rad51 (called Rhp51 in S. pombe)
(14, 15). Fbh1 is essential for viability in the absence of anti-
recombinases, such as Rqh1 and Srs2, and this synthetic lethal-
ity can be suppressed by inactivation of HR factors that pro-
mote presynaptic filament assembly (14). Moreover, Fbh1
limits Rad51-dependent recombination at blocked replication
forks in amanner dependent on its helicase/translocase activity
(16). Taken together, these findings suggest that Fbh1 regulates
HR through directly regulating Rad51 function, at least in
S. pombe.
Disruption of the Fbh1 gene in the chicken DT40 cell line
leads to elevated levels of sister chromatid exchange, a marker
of crossover during HR-mediated DNA repair (17). In contrast,
mouse Fbh1-deficient cells display no clear defect in HR-medi-
ated repair of DSBs but do show amoderate increase in RAD51
focus formation at sites of DNA damage (17, 18). In human
cells, FBH1 accumulates at sites of DNA damage and replica-
tion stress in a manner dependent on its helicase activity (19).
In order to gain insight into the role of FBH1 in mammalian
cells, we have taken a combined biochemical, biophysical, and
molecular genetic approach. We show that purified human
FBH1 is able to bind directly to RAD51 and to disrupt RAD51
filaments. Consistentwith this, analysis of amouse cell linewith
a defective FBH1 helicase indicates that the association of
RAD51 with chromatin is normally restrained by FBH1. Our
data provide mechanistic insight into the role of FBH1 as a
negative regulator of RAD51 function in order to prevent
unwanted HR.
EXPERIMENTAL PROCEDURES
Propagation of Mouse ES Cells—A totipotent, adherent
mouse ES cell line, designated R1, was obtained fromYusa et al.
(20). A derivative of R1, containing both copies of the Fbh1 gene
inactivated, was generated by the use two targeting vectors dif-
fering only in their drug resistance cassette. These vectors were
designed to delete helicase domains II and III, along with the
insertion of either a puromycin (pur)- or neomycin (neo)-resis-
tant gene plus an HSV domain. Confluent Buffalo rat liver
(BRL) cells were grown for 7 days at 37 °C in a humidified atmo-
sphere containing 5% CO2 in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% fetal calf serum
(FCS), 2.4 mM glutamine, and non-essential amino acids. The
medium was collected and used as conditioned medium for ES
cell culture. ES cells were grown in 50% DMEM and 50%
medium conditioned by BRL cells, supplemented with 10%
FCS, 2.4 mM glutamine, 1,000 units/ml murine leukemia inhib-
itory factor required by ES cells to maintain their pluripotent
state, non-essential amino acids, and 0.1% -mercaptoethanol.
Cell Cycle Analysis—Cells were treated with 10 g/ml BrdU
for 20min. Then cells were harvested and fixed in 70% ethanol.
Fixed cells were stained with BrdU antibody (1:10; BD Biosci-
ences), 40 g/ml propidium iodide, and 100 g/ml RNase A in
PBS. Cells were then labeled with secondary anti-mouse AF488
antibody (1:200; Invitrogen). Cell cycle distributions and BrdU
population were measured using a FACSCalibur flow cytome-
ter (BD Biosciences).
Clonogenic Survival Assays—The sensitivity of mouse ES
cells to increasing doses of DNA-damaging agents was deter-
mined using a clonogenic assay. Cells were trypsinized,
counted, and plated into 60-mm dishes coated with 0.1% por-
cine skin type A gelatin at a density of 1,000 cells/dish. Incuba-
tion was for a further 24 h, following which the cells were either
exposed to ionizing radiation or treated with drug-containing
medium for 2 h (cisplatin) or 24 h (camptothecin). After the
treatment period, cells were washed in PBS and then grown in
fresh medium. Incubation was for 6–8 days, following which
cells were washed in PBS, fixed, and stained with crystal violet.
Colonies were then counted using a Stuart Scientific Colony
Counter. Colonies containing more than 50 cells were counted
as survivors, and the number of colonies at each time point or
drug dose was expressed as a percentage of the colony number
in the untreated control. All time points were performed in
triplicate, and the experiment was repeated three times.
Sister Chromatid Exchange (SCE) Analysis—Mouse ES cells
were grown inmedium containing 10g/ml BrdU for 24 h. 100
ng/ml KaryoMAX Colcemid was added for the final 30 min of
the treatment period. The cells were then washed in PBS and
harvested by trypsinization. Cells were swelled in hypotonic
buffer containing 50 mM KCl before being incubated at 37 °C
for 30min. Fixing was in freshly made ice-cold fixative solution
(methanol/acetic acid, 3:1), and fixed cells were stored at
20 °C. To prepare the slides, the stored cells were resus-
pended in 1 ml of fresh, ice-cold fixative solution, and single
droplets from a Gilson P200 pipette were dropped from a
height of30 cm onto glass coverslips, followed by incubation
overnight in the dark at 42 °C. The slides were then stainedwith
20 g/ml bis-benzimide for 30 min, followed by exposure to
254-nmUV light in phosphate buffer, pH 6.8, for 3 h. The slides
were then incubated in prewarmed 2 SSC at 65 °C for 2 h
before staining with 0.8%MSGGiemsa for 3.5 min. Slides were
scored blindly using a Nikon Eclipse 80i microscope equipped
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with Lucia G software. 800–1,000 metaphase chromosomes/
cell line were examined, and an unpaired t test was used to
determine the significance in any difference in the distribution
of SCEs.
Immunofluorescence Analysis—Cells were seeded onto glass
coverslips coated with 0.5% gelatin at 25% confluence. 24 h
later, cells were left untreated or were treated with 100 nM
camptothecin and incubated at 37 °C. Cells were then fixed in
4% paraformaldehyde in PBS for 10 min, washed in PBS, and
stored at 4 °C. After permeabilization with 0.1% Triton X-100
in PBS, cells were washed and exposed to the primary antibody
(anti-Rad51 (1:5,000) (kindly provided by Dr. R. Kanaar) or
anti-H2AX (1:500) (Upstate)) for 16 h. Following this, the
samples were washed with 0.1% Triton X-100 in PBS and then
exposed for 30min to secondary antibody. After final washes in
0.1% Triton X-100 in PBS, the nuclei were counterstained with
DAPI Vectashields before the coverslips were sealed onto
glass slides. Nuclear staining patterns were visualized with a
confocal laser-scanningmicroscope (Zeiss LSM510Meta), and
images were stored and analyzed using Zeiss LSM Image
Browser software. Scoring was done either blindly by counting
the number of nuclear foci or alternatively by using ImageJ
software tomeasure the relative total nuclear fluorescence from
RAD51 staining. The differences between the cell lines were
evaluated statistically using unpaired t tests.
DR-GFP Assay—The puromycin-resistant gene in the DR-
GFP plasmid was excised using EcoRV and BspEI and blunt
end-ligatedwith a hygromycin-resistant gene under the control
of a PGK promotor to generate the DR-GFP-Hyg plasmid.
Mouse ES cells were electroporated with the DR-GFP-Hyg by
using a Bio-Rad electroporator (GenePulserXcellTM) at a single
pulse of 800 V and 3.0 microfarads. Stable transfected clones
were selected with 50 g/ml hygromycin. Cells containing the
DR-GFP-Hyg plasmidwere subjected into theDR-GFP assay as
described previously (21).
Plasmid Constructs and Proteins—The plasmid hFBH1/
pAS2-1 encoding for human FBH1 isoform 4 (2.91 kb, 969
amino acids) served as a source of FBH1 cDNA in this study
(12). FBH1 was subcloned as a fusion with glutathione S-trans-
ferase (GST) (N terminus) and hexahistidine tags (C terminus) in
pFastBac1 via SalI andKpnI sites to yield a transfer vector for bac-
midproduction.TheD698Nmutantof FBH1wasgeneratedusing
the QuikChange site-directed mutagenesis kit (Stratagene). To
produce antigen for anti-FBH1 antibody preparation, the N-ter-
minal part of FBH1 (isoform 4) including amino acids 1–484 was
subcloned into the pTYB12 vector via NheI/XhoI sites, creating a
fusion with an N-terminal self-cleavable affinity tag containing a
chitin-binding domain (CBD-FBH1(1–484)).
Antibodies—A polyclonal antibody against an FBH1 frag-
ment spanning amino acids 1–484 was raised in a chicken. The
antibody was extracted from egg yolk and affinity-purified
using a column conjugated with the antigen. A polyclonal anti-
body against the full-length humanRAD51was raised in rabbits
and affinity-purified using a RAD51-conjugated column.
Protein Purification—GST-FBH1-His6 (or its D698N mutant)
was produced in Sf9 insect cells by means of a baculovirus sys-
tem. Typically, 1.5  108 cells were infected by appropriate
virus and incubated for 2 days at 28 °C. Harvested cells were
resuspended in GST-lysis buffer (50 mM Tris-HCl, pH 8.0, 300
mM NaCl, 1 mM EDTA, 10% (v/v) glycerol, 2 mM DTT, 0.1%
(v/v) Triton X-100) and disrupted by Dounce homogenization.
The soluble protein extract obtained by centrifugation
(47,000 g for 45 min at 4 °C) was incubated with 2 ml of 50%
GSH-agarose for 2–4 h at 4 °C on a rotary shaker. Beads were
washed three times with 30 ml of GST-lysis buffer (centrifuga-
tion at 300 g for 5 min; 4 °C). FBH1 protein was eluted from
the beads by GST elution buffer (40 mM Tris-HCl, pH 8.1, 50
mM NaCl, 10% (v/v) glycerol) containing 10 mM glutathione.
Elution fractions containing FBH1 protein were pooled and
incubatedwith 0.5ml of 50% heparin beads for 1 h at 4 °C. After
binding, beads were washed three times with 20 ml of Hep-
bufferA (40mMTris-HCl, pH7.5, 0.1MNaCl, 1mMEDTA, 10%
(v/v) glycerol, 1 mM -mercaptoethanol), and protein was
eluted with Hep-buffer B (40 mM Tris-HCl, pH 7.5, 1 M NaCl, 1
mM EDTA, 10% glycerol (v/v), 1 mM -mercaptoethanol). The
heparin-elution fractions (1 ml) containing FBH1 were pooled
and dialyzed overnight at 4 °C against 1 liter of dialysis buffer
(40 mM Tris-HCl, pH 7.5, 50 mM NaCl, 1 mM EDTA, 40% (v/v)
glycerol, 1 mM -mercaptoethanol). The final protein prepara-
tionwas aliquoted, snap-frozen in liquid nitrogen, and stored at
80 °C. Protein concentration was measured by a Bradford
assay. RAD51, RAD51K133R, RPA, and RECQ5were produced
and purified as described previously (22–24).
Separation of Soluble and Chromatin-associated Proteins—
Semiconfluent cells were washed in PBS, trypsinized, and
counted. A pellet of 2  106 cells was washed three times in
PBS and resuspended in 250l of freshlymade protein buffer A
(10 mM HEPES, pH 7.0, 10 mM KCl, 1.5 mM MgCl, 0.34 M
sucrose, 10% (v/v) glycerol, 1mMDTT, 0.1% (v/v) TritonX-100,
and protease inhibitors). The sample was centrifuged at 210
g for 4min at 4 °C, and the supernatant was removed and stored
(cytoplasmic soluble fraction). The pellet was washed in 200 l
of protein buffer A and centrifuged at 210 g for 4 min at 4 °C
before the nuclei were lysed in 175l of freshlymade buffer B (3
mM EDTA, 0.2 mM EGTA, 1 mM DTT, protease inhibitors).
Incubation was for 10 min on ice, followed by centrifugation at
270  g for 4 min at 4 °C. The supernatant was removed and
stored (nuclear soluble fraction). The pellet was resuspended in
175l of buffer B and centrifuged at 16,000 g for 1min at 4 °C
before the supernatant was discarded, and the pellet was
resuspended (chromatin-associated fraction) in 175 l of
Laemmli buffer (4% SDS, 20% glycerol, 120 mM Tris-HCl, pH
6.8), boiled, and sheared with a 25-gauge needle. Storage of
all samples was at 80 °C. For analysis, 10 BFB-2-ME
(0.1% (w/v) bromphenol blue, 5% (w/v) -mercaptoethanol)
was added, the samples were boiled, and the soluble fractions
were combined. Proteins were separated on a 10% BisTris gel
with MOPS buffer. Proteins were transferred to a membrane
and probed with Rad51 antibody (1:200; Abcam), ORC4L
antibody (1:1,000; Abcam), or GRB2 antibody (1:1,000; BD
Transduction Laboratories).
GST Pull-down Assays—100 ng of purified RAD51 and 200
ng ofGST-FBH1-His (or 200 ng ofGST)were added to 0.4ml of
NET-N150 buffer (10 mM Tris-HCl, pH 8.0, 150 mM NaCl, 1
mM EDTA, 0.2% (v/v) Triton X-100) and incubated for 4 h at
4 °C on a rotary shaker. Where required, DTT was present at a
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concentration of 1 mM. 15 l of GSH-agarose slurry was added
to the protein mixtures, followed by incubation for another 1 h
at 4 °C. Beads were collected by centrifugation (300  g for 3
min at 4 °C), washed four times with 1 ml of NET-N150 buffer,
and incubated with 12 l of 2 Laemmli buffer at 95 °C for 5
min. Samples were subjected to SDS-PAGE on a 9% gel, fol-
lowed by Western blot analysis.
DNA Topology Modification Assays—Reactions were carried
out at 37 °C in a final volume of 25 l of buffer R (25 mM Tris-
HCl, pH 7.5, 50 mM KCl, 1 mM DTT, 1 mM MgCl2, 100 g/ml
BSA) supplemented with an ATP-regenerating system consis-
ting of 10 units/ml creatine phosphokinase, 12 mM creatine
phosphate, and 2 mM ATP. 2 M RAD51K133R was preincu-
batedwith circularM13mp8.32 ssDNA (9Mnucleotides) for 6
min, followed by the addition of 150 nM RPA and a DNA heli-
case (RECQ5 (80 and 160 nM), FBH1 (50, 160, 210, and 320 nM),
or FBH1D698N (320 nM)). After a 6-min incubation, topologi-
cally relaxed pGEM-7Zf() DNA (7 M base pairs) and 3 units
of wheat germ topoisomerase I (Promega) were added to com-
plete the reaction,whichwas then incubated for a further 8min.
Reactions were terminated by the addition of 5 l of STOP
buffer (6% (w/v) SDS, 0.1 M EDTA, 5 mg/ml proteinase K),
followed by a 25-min incubation at 37 °C. Deproteinized DNA
species were resolved by electrophoresis in a 1% agarose gel run
in 0.5 TBE buffer at 100 V for 2 h. Gels were stained with
ethidiumbromide (0.5g/ml) and photographed on aUV tran-
silluminator. DNA bands were quantified using ImageQuant
software, and the quantity of supercoiled DNA products was
expressed as a percentage of the amount of product gener-
ated in the reaction containing only RAD51K133R and
dsDNA (100%). To generate topologically relaxed dsDNA, 4
g of supercoiled pGEM-7Zf() DNA were incubated with
1.6 g of Escherichia coli topoisomerase I at 37 °C for 30 min
in 40 l of buffer R supplemented by 100 g/ml BSA. Reac-
tion was stopped by heat inactivation at 65 °C for 10 min.
Single-molecule Fluorescence Resonance Energy Transfer
(smFRET)—All experiments were performed at room temper-
ature. Reactions were carried out in buffer composed of 50 mM
Tris-HCl, pH 8.0, 50 mM KCl, and 10 mM MgCl2 and supple-
mented by an oxygen-scavenging system (1mg/ml glucose oxi-
dase, 0.4% (w/v) D-glucose, 0.02 mg/ml catalase, and 2 mM
Trolox) (25). smFRET assays were preformed according to pre-
viously described protocols (25, 26). Briefly, DNA FRET con-
structs (30 pM) were specifically tethered to the surface of a
biofunctionalized microfluidic chamber through a biotin-neu-
travidin link, followed by the addition of proteins.
smFRET Data Analysis—Data were recorded and analyzed
by scriptswritten in IDL to generate fluorescence intensity time
trajectories of individual molecules. A time resolution of 0.03 s
was used for all experiments. Single-molecule fluorescence
time trajectories were viewed and analyzed using programs
written in Matlab. FRET efficiency (EFRET) was approximated
as the ratio between the acceptor intensity and the sum of
the acceptor and donor intensities. Histograms were gener-
ated using a sample size of over 100 individual molecular
trajectories.
RESULTS
To investigate the function of the FBH1 helicase in themainte-
nance of genome stability, we undertook amultidisciplinary study
combining cellular, biochemical, and biophysical approaches.
Characterization of a Mouse ES Cell Line with a Helicase
Domain Deletion—To investigate the functional consequences
of inactivating the helicase activity of FBH1, we characterized a
previously described mouse ES cell line with a deletion in the
FBH1 helicase domain (27). In this cell line, a replacement of
each allele of the mouse Fbh1 gene region encoding helicase
domains II and III was made using a drug resistance cassette,
leading to termination of both Fbh1 open reading frames. Heli-
case domain II contains the Walker B box that is required for
binding the ATP-Mg2 complex and is essential, therefore, for
ATPase activity and hence DNA translocation-unwinding. The
correct targeting of the two Fbh1 alleles was verified previously
by PCR using multiple primer pairs along the Fbh1 gene (27).
To confirm that the targeted cells, hereafter called Fbh1hel/hel,
had a gene disruption that impacted on FBH1 protein levels, we
performed Western blot analysis. This analysis confirmed that
no detectable full-length FBH1 protein was expressed in the
Fbh1hel/hel cells (Fig. 1A). The doubling time, plating effi-
ciency, and cell cycle distribution of the Fbh1hel/hel cells were
all similar to those of the wild-type cells, indicating that there is
no gross disturbance in cell cycle or cell growth properties due
to loss of FBH1 helicase function in mouse ES cells (Fig. 1B)
(data not shown).
Next, we asked if theFbh1hel/hel cells showed any abnormal
survival response following exposure to DNA-damaging
agents. For this, clonogenic survival analyses were performed.
We tested a number of agents that damage DNA via different
mechanisms and produce lesions that are repaired by different
pathways. Of particular interest were agents that induce DNA
cross-linking or generate DNADSBs, either directly or through
replication fork collapse, because HR is normally required for
repair of these types of DNA damage. There was no difference
in survival between the wild-type and mutant cells for most
agents studied, including cisplatin and ionizing radiation (Fig.
1C) (data not shown). Nevertheless, there was a mildly
increased sensitivity to camptothecin in themutant cells, which
was statistically significant (IC50 of 150 nM for wild-type versus
105 nM for the Fbh1hel/hel cells; p 0.0035; Fig. 1D).
Fbh1hel/hel Cells Have Increased RAD51 Focus Formation
and Chromatin Association—Previous studies in fission yeast
cells have indicated that FBH1 is able to regulate the function of
RAD51. To investigatewhether thiswas conserved inmammalian
cells, we first quantified the level of nuclear RAD51 foci in the
wild-type andmutant cells that hadnot been exposed to any exog-
enous DNA damage stress. This revealed that the Fbh1hel/hel
cells exhibited a substantial excess of spontaneous RAD51 foci
compared with the wild-type cells (Fig. 2A). Only 2% of the
wild-type cells exhibited five or more foci (mean  0.98; n 
50), whereas 50% of the mutant cells contained at least five
RAD51 foci (mean  5.7; n  50; p  0.0001 compared with
wild-type cells). As an alternative method of quantification,
which took into account the observation that many nuclei in
the Fbh1hel/hel cell population contained extensive RAD51
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staining that was not limited to discrete focal sites, we quanti-
fied the total nuclear fluorescence intensity for the stained
RAD51. This showed that loss of Fbh1 helicase function led to a
highly significant increase in the level of overall nuclear RAD51
staining (n 75; p 0.0001; Fig. 2B). One possible explanation
for these data is that the staining pattern in Fbh1hel/hel cells
reflects a general increase in the level of DNA DSBs. However,
we consider this to be very unlikely, because the number of
spontaneous -H2AX foci was not altered in the mutant cells
(Fig. 2, C and D).
Next, we asked if this excessive RAD51 focus formation in
undamaged Fbh1hel/hel cells was also seen following exoge-
nously induced DNA damage. Following a dose of camptoth-
ecin that reduced cell survival by 25–50%, the number of
nuclear RAD51 foci was quantified at two time points after the
addition of the drug (2 and 4 h). We found that loss of Fbh1
helicase function was not associated with an increase in the
maximal number of RAD51 foci. After 2 h of camptothecin
exposure, RAD51 focus formation was increased relative to the
spontaneous level in both wild-type and mutant cells, but the
level was very similar in the two cell lines (Fig. 2, E and F). After
4 h, the level of RAD51 nuclear fluorescence was declining in
both cell lines, and the excess number of foci characteristic of
unperturbed Fbh1hel/hel cells compared with wild-type cells
was reestablished. Hence, FBH1 deficiency is associated with a
failure to suppress RAD51 focus formation but apparently only
in unperturbed or undamaged ES cells.
If the role of FBH1 is to prevent spontaneous RAD51 focus for-
mation in mammalian cells, as our data imply, then it might be
expected that the subnuclear distribution of RAD51 would be
abnormal in the Fbh1hel/hel cells. Consistent with this proposal,
we found that loss of FBH1 helicase function was associated with
an increase in the proportion of RAD51 that is chromatin-associ-
ated (Fig. 3, a and b). This differencewas not accounted for by any
change in the overall cellular level of RAD51 (Fig. 3c).
Fbh1hel/hel Cells Show Hyper-recombination and Resis-
tance to Poly(ADP-ribose) Polymerase (PARP) Inhibitors—
Next, we investigated whether the excess chromatin-bound
RAD51 was able to alter the spontaneous level of HR in the
Fbh1hel/hel. To study this, we initially quantified the fre-
quency of SCEs, which reflect crossover during HR events.
However, we found no significant difference in SCE levels
FIGURE 1. Characterization of Fbh1hel/hel cells. A, Fbh1hel/hel cells do not express any full-length FBH1 protein. Western blot of an extract from WT and
Fbh1hel/hel cells was immunoblotted for FBH1 and tubulin as a loading control. B, cell cycle distribution is only marginally altered in Fbh1hel/hel cells
compared withWT cells by FACS analysis. C, clonogenic survival of WT and Fbh1hel/hel cells following exposure to cisplatin.D, clonogenic survival of WT and
Fbh1hel/hel cells following exposure to camptothecin. The means and the S.E. (error bars) are shown for three independent experiments.
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between the wild-type and Fbh1hel/helmutant cells (p 0.05;
Fig. 4, A and B). Next, we quantified the frequency of HR more
generally using thewidely usedDR-GFP assay (see “Experimen-
tal Procedures”). In this, HR can be stimulated by the cleavage
of the GFP substrate with the I-SceI endonuclease to generate a
DNA double strand break. We found that I-SceI-induced HR
was significantly elevated in the Fbh1hel/hel cells compared
with the wild-type ES cell control (around 4-fold; p 0.01; Fig.
4C). Hence, we conclude that the excessive RAD51 focus for-
mation and chromatin binding associated with loss of FBH1
helicase activity has functional consequences and is capable of
activating at least some forms of HR.
Cells deficient in homologous recombination factors, such as
BRCA2, have been shown to exhibit hypersensitivity to inhibi-
tors of PARP (28–30). We analyzed, therefore, whether the
Fbh1hel/hel cellsmight showan altered response to PARP inhi-
bition. Consistent with the Fbh1hel/hel cells displaying hyper-
recombination rather than recombination deficiency, we found
that they were significantly more resistant to the PARP inhibi-
tor olaparib than the wild-type cells (p 0.05; Fig. 4D).
Direct Physical Interaction between Human FBH1 and
RAD51—Given that our cellular data are consistent with FBH1
acting as a negative regulator of the association of RAD51 with
chromatin, we investigatedwhether theremight be a functional
interaction between RAD51 and FBH1 proteins in vitro. To test
whether FBH1 can physically interact with RAD51, we purified
recombinant GST-tagged FBH1 and untagged RAD51 (Fig. 5A)
and then performed affinity pull-down assays. The RAD51
was incubated with GST-FBH1 or with GST alone under
either reducing or non-reducing conditions. The GST-FBH1
and GST proteins were subsequently captured on glutathi-
one-agarose beads, and any additional bound proteins were
eluted and analyzed by Western blotting. We found that
RAD51 could bind to the GST-FBH1 beads but not to control
GST beads (Fig. 5B, lanes 1–4). Notably, reducing condi-
tions increased the extent of binding of GST-FBH1 and
RAD51 (Fig. 5B, compare lanes 2 and 4). Collectively, these
data indicate that FBH1 forms a complex with RAD51
through a direct interaction, as might be expected of a reg-
ulator of RAD51 function.
FIGURE 2. Fbh1hel/hel cells cannot regulate RAD51 focus formation. A, examples of RAD51 foci (green) in WT and Fbh1hel/hel cells. Nuclei were stained
with DAPI (blue). B, relative total nuclear fluorescence for RAD51 staining in WT and Fbh1hel/hel cells. Data were analyzed using ImageJ. The means and S.E.
(error bars) are shown for three independent experiments. C, examples of nuclei stained for -H2AX (green). Nuclei were stained with DAPI (blue). D, quantifi-
cation of the data fromC. E, images ofWT and Fbh1hel/hel cells 2 h after exposure to 100 nM camptothecin. RAD51 foci are shown in green. Nuclei were stained
with DAPI (blue). F, quantification of the data from E, along with equivalent data from time 0 and 4 h. The mean number of nuclear RAD51 foci is shown. S.E.
values from at least three independent experiments are indicated.
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FBH1 Disrupts RAD51 Nucleoprotein Filaments in Vitro—
Next, we investigatedwhether purified FBH1 protein could dis-
rupt RAD51 filaments in vitro. In these experiments, we used an
ATPase-defective mutant of RAD51, RAD51K133R, which has
been shown to form stable filaments in the presence of ATP,
which wild-type RAD51 does not (31). RAD51K133R-ssDNA
FIGURE3.Abnormal subcellulardistributionofRAD51 inFbh1hel/hel cells.A,Westernblot of the chromatin fraction and solubleprotein fractionof RAD51
(top), ORC4L (a chromatin marker; middle), and GRB2 (a soluble fraction marker; bottom). B, quantification of the Western blots from A showing the relative
distribution of RAD51 in the chromatin and soluble factions. In each case, theWT cells were given a value of 1. C, Western blot comparing total cellular RAD51
levels to those of a loading control (tubulin).
FIGURE 4. Hyper-recombination in Fbh1hel/hel cells. A, representative image of metaphase chromosomes from Fbh1hel/hel cells stained for SCEs. The
enlargementon the right shows an SCE.B, quantificationof SCEdata forWT (yellowbars) and Fbh1hel/hel (blue bars) cells. Thenumber of SCEs per chromosome
is shown. The key indicates themean and S.D. fromover 700 chromosomes in each case (p 0.05). C, hyper-recombination in Fbh1hel/hel cells as determined
using theDR-GFP assay. The percentage of cells expressingGFPwas normalized to a transfection control (a plasmid expressing RFP). The values above the bars
indicate the average percentages. Themeans and S.E. (error bars) for three independent experiments are shown.D, clonogenic survival ofWT and Fbh1hel/hel
cells following exposure to olaparib. The means and the S.E. are shown for three independent experiments.
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filaments were preformed on M13 ssDNA and were then incu-
bated with increasing concentrations of GST-FBH1 in the pres-
ence of RPA andATP. Following this, a previously validatedDNA
topology assay was performed that permits detection of free
RAD51molecules in solution (10). In this assay, bindingofRAD51
to topologically relaxed, covalently closed circular dsDNA induces
lengthening of the DNA and the formation of positive supercoils.
This effect can be monitored as a reduction in the DNA linking
number upon treatment with eukaryotic topoisomerase I, giving
rise to negatively supercoiled DNA (10, 32). We observed that
FBH1promoted the formation of the negatively supercoiledDNA
product in a concentration-dependent manner, indicative of the
presence of a filament-disrupting activity (Fig. 5,C andD). Forma-
tion of supercoiledDNAwas not detected in reactions containing
an ATPase-defective mutant of FBH1, FBH1-D698N, indicating
that filament disruption by wild-type FBH1 is dependent on its
ssDNA translocase activity, which is driven by ATP hydrolysis
(Fig. 5, C and D). Moreover, FBH1 alone did not induce DNA
supercoiling in a DNA topology modification assay (Fig. 5, C and
D, lane 10). We also carried out control reactions in which the
FBH1proteinwassubstitutedby theRECQ5helicase,which isalso
known to bind RAD51 (33). We found that RECQ5 disrupted
RAD51K133R-ssDNA filaments in a manner similar to that of
FBH1 (Fig. 5,C andD).
Real Time Observation of RAD51 Filament Disruption by
FBH1—To substantiate and extend the findings described
above, we used smFRET-based assays to monitor FBH1-medi-
ated disruption of RAD51-ssDNA filament in real time. To
probe RAD51 filament assembly and disassembly on ssDNA,
we used two partial duplex FRET constructs. Both contained an
18-bp duplex region but differed in whether they had a 20- or a
30-nt poly(dT) 3	 tail, as illustrated in Fig. 6A. The 3	-terminus
of the dT20 tail construct was labeled with a Cy3 (donor) dye
molecule, whereas the dT30 tail was labeled internally 14 nt
away from the 3	-end. In both cases, the 5	-end of the ssDNA/
dsDNA duplex junction was labeled with a Cy5 (acceptor) dye
molecule. These FRETconstructs exhibited a steady state FRET
efficiency (EFRET) of 0.6 (Fig. 6, C and D, blue histograms;
illustrated in Fig. 6B), making them suitable for monitoring
RAD51 filament-mediated extension of the contour length of
the ssDNA, a known feature of such filaments. We established
that these partial duplex substrates possess, as expected, an
ssDNA 3	-tail that is longer than the experimentally deter-
mined minimal length (16 nt) required for stable RAD51-
ssDNA filament formation (34). The DNA-FRET substrates
were specifically tethered to the surface of the flow chamber via
a biotin moiety on the blunt end of the duplex (Fig. 6A). We
utilized two different probes to rule out the possibility that our
observations were specific for a particular DNA substrate.
However, because both of these FRET substrates yielded very
similar data, we focused on the results obtained with the 30-nt
tailed substrate. For consistency, the concentration of surface-
tethered DNA was fixed at 30 pM in all experiments.
FIGURE 5. FBH1 forms a complex with RAD51 and disrupts RAD51 filaments. A, SDS-PAGE analysis of purified FBH1 (left) and RAD51 (right). Gels were
stainedwithCoomassie Blue. Themolecularmassesof protein standards are indicatedon the right.B, GSTpull-downassay. PurifiedRAD51protein (100ng)was
incubated with GST-FBH1-His (FBH1) protein or with GST alone (each 200 ng) in the presence or absence of 1 mM DTT (DTT/DTT). Proteins were affinity-
captured using GSH-agarose beads and analyzed by Western blotting (WB) using chicken anti-FBH1 and rabbit anti-RAD51 antibodies. Lane 5, FBH1 (40% of
input); lane 6, RAD51 (5% of input). C, RAD51K133R was assembled on M13 ssDNA (9 M nucleotides) in the presence of 2 mM ATP and an ATP-regenerating
system and was then incubated with increasing concentrations of FBH1 (50, 160, 210, and 320 nM) or RECQ5 (80 and 160 nM) for 6 min before the addition of
relaxedDNA (7Mbp) andwheat germDNA topoisomerase I. After deproteinization, reactionswere analyzedby electrophoresis in a 1%agarose gel, followed
by ethidium bromide staining. Gels were quantified using ImageQuant software, and the concentration of supercoiled DNA products was calculated as a
percentage of the amount of product generated in the reaction carried out in the absence of ssDNA, FBH1/RECQ5, and RPA (lane 2). D, quantification of the
data. The plot shows the average values from three independent experiments performed as described in C. The numbers under the bars correspond to the
numbers of lanes in C. Error bars, S.D.
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Togenerate a stable RAD51-ssDNA filament, we added a 500
nM concentration of the RAD51K133R protein, together with 4
mM ATP, to the flow chamber and incubated the reaction for
5 min before data acquisition. Formation of RAD51K133R-
ssDNA filaments was observed as a dramatic decrease in EFRET
(from0.6 to0.3 and0.1 for the 30- and 20-nt substrates,
respectively), resulting from the RAD51-dependent extension
in ssDNA contour length in the filament (Fig. 6, C and D, gray
histograms; illustrated in Fig. 6B). RAD51K133R was found to
form stable filaments on the ssDNA, as evidenced by the nar-
row FRET distribution of smFRET histograms. This was also
apparent in themajority of smFRET trajectories, which showed
a steady low FRET state (EFRET 0.1 and 0.3 for the 20- and
30-nt substrates, respectively; Fig. 6,C andD), corresponding to
stable RAD51-ssDNA filaments. There were occasional transi-
tions to higher FRET states (EFRET0.4–0.5), probably reflect-
ing the dynamics of RAD51 filament rearrangement. Fig. 6E
shows a representative single-molecule trajectory of a
RAD51K133R-ssDNA filament, where the top panel displays
the donor (green) and acceptor (red) intensities and the bottom
panel shows the corresponding FRET efficiency (blue). The
smFRET trajectory shows that the RAD51K133R protein
forms a stable filament, corresponding to a lower FRET value
(0.3; dashed line). Hence, we conclude that RAD51K133R
protein can generate stable filaments under our experimental
conditions.
To verify that spontaneous RAD51K133R filament disassem-
bly would not mask FBH1-mediated disassembly, we moni-
tored the stability of RAD51K133R-ssDNA over time. Follow-
ing initial filament assembly, the flow chamber was washed
with imaging buffer to remove excess RAD51K133R in solu-
tion, and DNA substrates were monitored again 30 and 60 min
later. The smFRET histogram obtained 60 min after excess
RAD51K133R removal was very similar to the histogram
obtained immediately after filament formation, indicating that
the RAD51K133R filament is stable on ssDNA for a prolonged
time (data not shown). We also verified that the observed
decrease in FRET was indeed due to RAD51K133R-ssDNA fil-
ament formation by using a high salt (500 mM NaCl) buffer to
remove all bound proteins. As anticipated, the smFRET histo-
grams obtained after high salt buffer wash were identical to the
initial smFRET histograms obtained for DNA only (data not
shown).
We next characterized the behavior of FBH1 on the tailed
DNA substrate in the absence of RAD51. 50 nM FBH1 along
with 1 mM ATP were added to the flow chamber containing
surface-tethered DNA-FRET substrates, and data were
recorded immediately thereafter. We found unwinding of the
surface-tethered DNA by FBH1, as evidenced by the rapid
reduction of the observed FRET molecules on the surface (Fig.
7, A and B). Quantification of FBH1 unwinding efficiency (Fig.
7B), calculated as the percentage of molecules removed within
the first 2 min of the unwinding reaction, showed that FBH1
unwinds more than 50% of the surface-bound DNA molecules
within this time period. We also tested FBH1 unwinding
activity using DNA substrates on which WT RAD51 or
RAD51K133R filaments were preformed. This was achieved by
the addition of 500 nM WT RAD51 or RAD51K133R protein
together with 4 mM ATP and incubation for 5 min prior to the
addition of FBH1. Notably, the efficiency of FBH1-mediated
FIGURE 6. Single-molecule FRET assay for RAD51-ssDNA filament formation. A, illustration of the DNA FRET substrates used in our assays, consisting of
partial duplex DNA with a dT30 or dT20 tail. B, illustration of single-molecule RAD51-ssDNA filament assembly assays. The DNA substrate shown on the left
yields high FRET at steady state. Upon the addition of RAD51 and ATP, a RAD51-ssDNA filament forms, extending the ssDNA, resulting in a decrease in FRET
(right).C andD, FREThistogramsof a populationof individualDNAmolecules for the 20-nt (C) and30-nt (D) substrates, showing the resulting FRET valueswhen
ssDNA is relaxed (DNA only; blue histogram) and after the assembly of a RAD51K133R-ssDNA filament, resulting in a FRET decrease (gray). E, representative
smFRET trajectory of a 30-nt DNA substrate with a RAD51K133R-ssDNA filament. The top panel shows the donor and acceptor intensities, whereas the
corresponding FRET efficiency is shown in thebottompanel. The FRET efficiency associatedwith stable RAD51K133R-ssDNA ismarkedwith ahorizontal dashed
line.
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unwinding of DNA containing preformed RAD51 filaments
showed only a modest decrease in efficiency when using WT
RAD51 but nearly complete suppression of unwinding when
usingRAD51K133R filaments (Fig. 2B). As expected, analysis of
individual FRET trajectories acquired during FBH1 unwinding
reactions displayed rapid, repetitive FRET fluctuations, indica-
tive of ATP-dependent translocation activity, which has been
reported previously for other helicases (35, 36). Fig. 7C shows a
characteristic single-molecule FRET trajectory in the presence
of FBH1 and ATP, where the donor-acceptor intensities and
corresponding FRETefficiency are shown in the top and bottom
panels, respectively. The smFRET trajectory shows a clear
repetitive fluctuation induced by FBH1 translocation on
ssDNA, observed as recurring transitions from high FRET
base-line value to lower FRETvalues. This characteristic behav-
ior was also observed with the 20-nt tailed DNA substrates
(data not shown).
Next, we analyzed FBH1-mediated disruption of a pre-
formed RAD51K133R-ssDNA filament. For this, a stable
RAD51K133R-ssDNA filament was formed by incubating the
surface tethered DNA substrate with RAD51K133R and 4 mM
ATP for 5 min. Thereafter, excess RAD51K133R was removed,
and FBH1 (50 nM) and ATP (1 mM) were added (illustrated in
Fig. 8A). Data acquisition followed immediately. The resulting
histograms (Fig. 8, B and C, for the 20- and 30-nt substrates,
respectively) display a clear broadening of the peak correspond-
ing to the RAD51K133R-ssDNA filament (0.3 and 0.1 for
the 30- and 20-nt substrates, respectively) together with the
appearance of another FRET population at 0.6, correspond-
ing to removal of the RAD51K133R-ssDNA filament from
ssDNA tail. The broadening of the low FRET RAD51K133R-
ssDNA filament peak in the presence of FBH1 (Fig. 8, B and C;
comparedwith the narrower peak (Fig. 6,C andD)) is indicative
of the dynamics of the RAD51K133R-ssDNA filaments
resulting from FBH1 translocation. The formation of two
distinct FRET populations upon the addition of FBH1
strongly suggests that translocation-mediated directional
removal of RAD51K133R from ssDNA is occurring. This is
probably initiated at the 3	-end of the DNA. A broad, continu-
ous FRET distribution would be expected if random binding
and translocation were to occur along the ssDNA tail.
Analysis of individual single-molecule FRET trajectories
revealed direct filament disruption events, where the low FRET
values corresponding to RAD51K133R-ssDNAbase line (0.3)
were now accompanied by low amplitude repetitive transitions
to higher FRET. Fig. 8, D and E, shows three representative
smFRET trajectories showing RAD51K133R-ssDNA filament
disassemblymediated by FBH1.The trajectory shown in Fig. 8D
displays repetitive FRET modulation occurring around the
RAD51K133R-ssDNA filament FRET base line (as compared
with the RAD51K133R-ssDNA filament shown in Fig. 6E). This
may indicate that FBH1 first binds and clears RAD51K133R
from ssDNA at the 3	-end and undergoes repetitive transloca-
tion, hence destabilizing the RAD51K133R-ssDNA filament
that is still bound further down the ssDNA strand (34). Fig. 8E
shows that the fluctuations in RAD51K133R-ssDNA FRET
base line (t  0–23 s) are followed by an abrupt transition to
higher FRET, where the RAD51K133R protein is removed.
These observations denote FBH1 translocation-dependent
RAD51-ssDNA filament disassembly. Similar features were
also observed in trajectories obtained from the 20-nt tailed
FRET substrate (data not shown).
To further verify that the observed filament disruption is due
to FBH1 ATPase activity, we repeated the RAD51K133R-
ssDNA disruption experiment with the ATPase-defective
mutant of FBH1, FBH1-D698N, and 1 mM ATP. This resulted
in no substantial disruption of RAD51 filament, even for the
shorter 20-nt substrate, as shown in Fig. 8F (as compared with
wild-type FBH1; Fig. 8, B and C), indicating that the RAD51-
ssDNA filament disruption is indeed due to FBH1 ATP-depen-
dent ssDNA translocation, as has been observed previously for
yeast Srs2 protein (34).
FIGURE 7. Unwinding of a duplex DNA substrate by FBH1. A, unwinding of 30-nt tailed DNA substrate illustrated on the left. The images show spots
corresponding to individualmoleculesobserved in thedonor (left) andacceptor (right) channels. Following theadditionof FBH1andATP (right), there is a sharp
reduction in the number of observed DNA molecules. B, unwinding yield calculated for the initial 2 min of the unwinding reaction, showing that rapid
unwinding is dramatically reduced in thepresence of a RAD51K133R filament.C, representative smFRET trajectory showing repetitive translocationof FBH1on
the DNA FRET substrate in the absence of a RAD51-ssDNA filament. Error bars, S.E.
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DISCUSSION
The FBH1 helicase has been implicated in the regulation of
the RAD51 recombinase in a number of organisms, including
fission yeast, as well as chicken and mammalian cells (14–19).
Here, we have defined the molecular mechanism underlying
the anti-recombinase activity of FBH1 in mammalian cells.
Using biochemical and biophysical techniques, we have dem-
onstrated that human FBH1 has the capacity to disrupt the
ATP-bound form of the RAD51 presynaptic filament by acting
as a ssDNA translocase. This serves to expel RAD51monomers
from the ssDNA. A similar activity has been shown previously
for human RECQ5, which belongs to a different family of heli-
cases from FBH1 (RecQ, not UvrD) (33). Thus, mammalian
cells possess at least two evolutionarily divergent helicases that
can regulate RAD51 filament assembly by a mechanism similar
to that shown for the canonical enzyme in yeast, Srs2. It
remains to be determined whether FBH1 and RECQ5 have
redundant roles in HR regulation or whether they act in differ-
entHRpathways. Evidence in favor of the latter proposal comes
from the finding that RecQ5-deficient mouse cells show
increased levels of RAD51 foci that are accompanied by exces-
sive SCEs and -H2AX foci (33), neither of which are seen in
our mouse Fbh1hel/hel cells. Other putative regulators of
RAD51 are expressed in human cells, including PARI, BLM,
and HelQ, but none of these has properties identical to FBH1.
PARI appears to be the closest mammalian homolog of yeast
Srs2. However, PARI lacks key residues essential in other UvrD
family proteins for DNA translocation (11), making it very
unlikely that it disrupts RAD51 filaments via a similar, translo-
cation-based, mechanism to that used by FBH1. In contrast to
FBH1, BLM is incapable of disrupting the ATP-bound form of
RAD51 but instead was reported to stimulate DNA strand
exchange by ATP-bound RAD51 (37, 38). HelQ also behaves
differently from FBH1, in that it seems to be specific for RAD51
bound to dsDNAand to utilize anATP-independent disruption
mechanism (39). Taken together, these data suggest that FBH1
has properties that distinguish it from any of the other known
RAD51 regulators in mammalian cells.
A previous study (18) suggested that the primary role of
FBH1 in mammalian cells is in the control of mitosis, more
specifically in restoring normal progression through mitosis
following exposure of cells to catalytic inhibitors of topoi-
somerase II that prevent normal sister chromatid disjunction.
This conclusionwas based on analysis ofmouse ES cells lacking
Fbh1 or expressing F-Box-deficient Fbh1. In contrast to those
cell lines, we studied ES cells expressing helicase-deficient
Fbh1. Our Fbh1hel/hel mutant cells are not hypersensitive to
topoisomerase II catalytic inhibitors,6 unlike the ES mutants
6 M. J. Payne, W. K. Chu, K. Hanada, and I. D. Hickson, unpublished data.
FIGURE 8. Single-molecule FRET analysis of the FBH1-RAD51 interaction. A, illustration of the DNA FRET assay for single-molecule, FBH1-mediated,
RAD51-ssDNA filament disassembly. The addition of FBH1 to a preformed RAD51 filament causes filament disassembly enabling relaxation (shortening) of
ssDNA and an increase in FRET efficiency. B and C, FRET histograms after the addition of FBH1 and ATP to a preformed RAD51K133R-ssDNA filament for the
20-nt (B) and 30-nt (C) substrates.D and E, representative smFRET trajectories of the dynamics associatedwith repetitive translocation of FBH1 on ssDNA in the
presence of a RAD51K133R filament and FBH1-mediated RAD51K133R-ssDNA filament disassembly. The FRET efficiency corresponding to a RAD51K133R-
ssDNA filament (dashed line) displays changes due to repetitive FBH1 ssDNA translocation that fluctuate around the filament base line (D), indicating the
co-existence of FBH1 and the RAD51K133R filament. E, fluctuations of FRET corresponding to FBH1 translocations in the presence of RAD51K133R-ssDNA
filament, followed by an abrupt increase to higher FRET due to the removal of RAD51K133R filament. F, FRET histogram after the addition of FBH1-D698N
mutant (ATPase-dead) and ATP to a preformed RAD51K133R-ssDNA filament for the 20-nt DNA, showing the persistence of the RAD51K133R filament.
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described by Laulier et al. (18). Other than the obvious differ-
ence in genotype of the ES cells characterized in the Laulier et
al. (18) study and ours, we do not have a clear explanation for
why we see hyper-recombination, but they did not, and why we
do not see obvious mitotic defects. In Schizosaccharomyces
pombe, Fbh1 appears to function as a dedicated HR factor, and
moreover, many of the phenotypes seen in S. pombe fbh1
mutants are seen in our Fbh1hel/hel mutant cells. Hence, we
believe that our data are consistent with the evolutionarily con-
served role of Fbh1 being in the regulation of HR.
An unexpected feature of mouse ES cells deficient in FBH1
helicase function is hyper-recombination for some, but not all,
forms of HR. It will be informative in future studies to define
whether FBH1 possesses an inherent ability to regulate only
some forms of HR or whether RAD51 itself is differentially sen-
sitive to the action of FBH1, depending on the circumstances.
One possibility would be that RAD51 post-translational modi-
fications influence the ability of FBH1 to disrupt the nucleopro-
tein filament. Our data suggest that replication-associated HR
that generates SCEs is insensitive to the effects of FBH1,
whereas DSB-induced HR is far more effectively regulated by
FBH1. Loss of FBH1 helicase function also does not impact
strongly on the cell death response following DNA damage, at
least not with the range of agents that we analyzed. This indi-
cates that FBH1 helicase deficiency does not markedly impair
HR repair functions required for viability in mouse cells. In the
Fbh1hel/hel mutant cells, the frequency of DSB-induced HR
was strongly elevated, as determined by the widely used DR-
GFP assay. This assay is designed to measure non-crossover
forms ofHR thatmost likely derive from repair eventsmediated
by the synthesis-dependent strand-annealing pathway (21).
Taken together with the lack of altered SCE levels in Fbh1hel/hel
cells, which reflect crossover recombination events, we propose
a working model in which FBH1 acts as a negative regulator of
the synthesis-dependent strand-annealing pathway, but only in
cells that are not experiencing excessive DNA damage. This
activity would have the effect of preventing spontaneous syn-
thesis-dependent strand-annealing reactions being initiated
inappropriately. However, when cells are damaged, FBH1 is
apparently no longer functional in restraining RAD51. Hence, a
mechanism must exist to suppress the action of FBH1 in cells
experiencing DNA damage, thus derepressing RAD51 function
to permit essential HR reactions to proceed. This would be
logical and consistent with the notion that RAD51-dependent
HR is essential for survival in cells exposed to DNA-damaging
agents. Interestingly, and consistent with their hyperrecombi-
nation phenotype, the Fbh1hel/hel cells are more resistant
than wild-type cells to the PARP inhibitor olaparib. It is known
from previous studies that recombination-deficient cells are
hypersensitive to PARP inhibitors (29–31). However, our data
indicate that the reciprocal relationship is seen in Fbh1hel/hel
cells, namely hyperrecombination accompanied by PARP
inhibitor resistance. Hence, our data also suggest that the rela-
tive sensitivity of cells to PARP inhibitors correlates closely
with their overall recombination efficiency and could have
implications for anti-tumor therapies based on the use of PARP
inhibitors.
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